Article information
Abstract
Scedosporium species are an emerging opportunist group of fungi that have been found to cause infections in both immunocompetent and non-immunocompetent individuals. The infections are not regularly distributed among different countries of the world either because of improper identification or other geographical reasons. Strange as it may, disseminated systemic infections have only been reported in some specific countries. We used a mouse model of disseminated infection to assess if strains from Nigeria were virulent and compared it to a few other strains from other countries. S. apiospermum isolated from Nigeria were clearly less virulent than those obtained elsewhere. This may be the reason why this group of fungi has not been associated with specific clinical problems in Nigeria in pa’rticular and Africa in general.
Keywords:
Scedosporium
inocula
virulence
fungi
Full text is only aviable in PDF
References
[1.]
F. Gilgado, J. Cano, J. Gené, et al.
Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the new species Scedosporium dehoogii.
J Clin Microbiol, 46 (2008), pp. 766-771
[2.]
F. Gilgado, C. Serena, J. Cano, et al.
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Antimicrob Agents Chemother, 50 (2006), pp. 4211-4213
[3.]
J. Pontón, R. Rüchel, K.V. Clemons, et al.
Emerging pathogens.
Med Mycol, 38 (2000), pp. S225-S236
[4.]
J. Berenguer, J. Diaz-Mediavilla, D. Urra, P. Muñoz.
Central Nervous System Infection Caused By Drosophila melanogaster: Case Report and Review.
Rev Infect Dis, 11 (1989), pp. 890-896
[5.]
G.S. De Hoog, J. Guarro, J. Gené, M.J. Figueras.
Atlas of Clinical Fungi.
Utrecht: Centraalbureau Voor Schimmelcultures, 2nd edn., Universitat Rovigili, (2000),
[6.]
A.J. Carrillo, J. Guarro.
In Vitro Activities of Four Novel Triazoles Against Scedosporium Spp.
Antimicrob Agents Chemother, 45 (2001), pp. 2151-2153
[7.]
F. Gilgado, J. Cano, J. Gené, J. Guarro.
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species.
J Clin Microbiol, 43 (2005), pp. 4930-4942
[8.]
J. Capilla, J. Guarro.
Correlation between in vitro susceptibility to voriconazole and in vivo outcome of Scedosporiosis in Guinea pigs.
Antimicrob Agents Chemother, 48 (2004), pp. 4009-4011
[9.]
R. Fienberg.
Madura Foot in a Native American.
Am J Clin Pathol, 14 (1944), pp. 239-246
[10.]
L. Ajello.
The isolation of Allescheria boydii shear, an etiologic agent of mycetomas, from soil.
J Trop Med, 1 (1952), pp. 227-238
[11.]
A.C. Reyes.
A contribution to the study of mycetoma in the Philippines: maduromycosis caused by Monosporium apiospermum (laboratory studies).
Acta Med Philipp, 19 (1963), pp. 89-102
[12.]
J.A. Schmitt, R.J. Zabransky, A.S. Janidlo, J.E. Parsons.
Experimental Maduromycosis In The Laboratory Mouse.
Mycopathologia, 18 (1962), pp. 164-168
[13.]
R.G. Bell.
Comparative Virulence and Immunodiffusion Analysis of Petriellidium boydii (Shear).Malloch Strains Isolated from Feedlot Manure and a Human Mycetoma.
Can J Microbiol, 24 (1978), pp. 856-863
[14.]
M. Ortoneda, F.J. Pastor, E. Mayayo, J. Guarro.
Comparison Of The Virulence Of Scedosporium prolificans Strains From Different Origins In A Murine Model.
J Med Microbiol, 51 (2002), pp. 924-928
[15.]
J. Cano, J. Guarro, E. Mayayo.
Experimental Infection with Scedosporium inflatum.
J Med Vet Mycol, 30 (1992), pp. 413-420
[16.]
G.A. Lamaris, G. Chamilos, R.E. Lewis, D.P. Kontoyiannis.
Virulence studies of Scedosporium and Fusarium species.
Drosophila melanogaster, 196 (2007), pp. 1860-1864
[17.]
F. Gilgado, J. Cano, J. Gené, C. Serena, J. Guarro.
Different virulence of the species of the Pseudallescheria boydii complex.
Medical Mycology, 47 (2009), pp. 371-374
[18.]
L. Delhaes, A. Harun, S.C. Chen, et al.
Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.
Emerg Infect Dis, 14 (2008), pp. 282-290
[19.]
P. Troke, K. Aguirrebengoa, C. Arteaga, et al.
Treatment of scedosporiosis with voriconazole experience with 107 patients.
Antimicrob Agents Chemother, 52 (2008), pp. 1743-1750
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
